Taxoids clinical trials
A group of medicines. Paclitaxel (1,755 studies) and Docetaxel (1,164 studies) are counted on their own pages; this page counts the studies that name Taxoids itself.
How each study uses Taxoids is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Get an email when these change. Save the Taxoids studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your saved searches, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your saved searches. Stop any time.
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorisations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Name
- Taxanes
- 2
Medicines filed under Taxoids
As reviewed, so not every one. Each counts its studies on its own page, not here.
Studies by the year they started
5 studies that test it; most in 2016 (1)
| Year | Studies |
|---|---|
| 2016 | 1 |
| 2020 | 1 |
| 2024 | 1 |
| 2025 | 1 |
| 2026 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 1 · Other 4
Hebei Medical University Fourth Hospital (2) · Shanghai Jiao Tong University School of Medicine (1) · Cancer Institute and Hospital, Chinese Academy of Medical Sciences (1) · SUNHO(China)BioPharmaceutical CO., Ltd. (1)
Often tested with
Tested in the same studies.
Pyrotinib (2) · Trastuzumab (1) · Epirubicin (1) · Cyclophosphamide (1) · Carboplatin (1) · Trastuzumab rezetecan (1) · Adebrelimab (1) · IAE0972 (1)
Coming up
From the study records. Dates are the sponsors’ own estimates and often move.
Reaching primary completion within a year · 2, 2 in phase 3
Studies that test Taxoids, phase 3 first.
- Dec 2026Neoadjuvant Chemotherapy With Pyrotinib, Epirubicin and Cyclophosphamide Followed by Taxanes and Trastuzumab for HER-2+ Breast CancerPhase 2/3 · Hebei Medical University Fourth Hospital
- Mar 2027Adjuvant Treatment of EC Followed by Taxane +/- Carboplatin in Triple-Negative Breast CancerPhase 3 · Shanghai Jiao Tong University School of Medicine
Studies
Open first, then newest update. How each study uses Taxoids is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 5
- Chemotherapy With or Without Adebrelimab and T-DXh as Neoadjuvant Therapy for HR+/HER2 Low Early Stage Breast CancerNot yet recruitingPhase 2Cancer Institute and Hospital, Chinese Academy of Medical SciencesNCT07317778Written as Taxane Chemotherapy
- A Clinical Trial to Evaluate Effect of IAE0972 Combined with Chemotherapy for R/M HNSCC or NPC(Note: It is Currently Phase II.).Not yet recruitingPhase 2/3SUNHO(China)BioPharmaceutical CO., Ltd.NCT06719479Written as IAE0972+Taxanes
- The Efficacy and Safety of Pyrotinib, Trastuzumab Combined With Taxanes in the Treatment of Trastuzumab-treated HER2+ Advanced Breast Cancer (ABC).Active, not recruitingPhase 4Hebei Medical University Fourth HospitalNCT06217185Written as Taxanes
- Neoadjuvant Chemotherapy With Pyrotinib, Epirubicin and Cyclophosphamide Followed by Taxanes and Trastuzumab for HER-2+ Breast CancerActive, not recruitingPhase 2/3Hebei Medical University Fourth HospitalNCT04290793Written as Taxanes
- Adjuvant Treatment of EC Followed by Taxane +/- Carboplatin in Triple-Negative Breast CancerActive, not recruitingPhase 3Shanghai Jiao Tong University School of MedicineNCT02455141Written as Taxanes
Given beside what is tested · 4 — Taxoids is usual care or a partner of the new treatment
- Pharmacokinetics and Safety of Epidiferphane and Taxanes in Breast Cancer PatientsRecruitingPhase 1/2University of FloridaNCT05074290Written as Taxane Chemotherapy
- Neoadjuvant Trastuzumab Deruxtecan (SHR-A1811) + Pertuzumab in HER2+ Breast CancerRecruitingPhase 2Shanghai Jiao Tong University School of MedicineNCT07393425Written as Taxane Chemotherapy
- TKIs vs. Pertuzumab in HER2+ Breast Cancer Patients With Active Brain Metastases (HER2BRAIN)Not yet recruitingPhase 2Second Affiliated Hospital, School of Medicine, Zhejiang UniversityNCT04760431Written as Taxanes
- Phase I/IIa Study of Pharmacokinetics and Safety of Epidiferphane™ and Taxanes in Breast Cancer PatientsWithdrawnPhase 1/2University of FloridaNCT03611985Written as Taxane Chemotherapy